MoveByBike (MBBAB) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Net sales increased to 6,929 TSEK in Q1 2025 from 5,812 TSEK year-over-year, mainly driven by growth in Copenhagen operations.
Net loss after tax improved to -6,345 TSEK from -9,958 TSEK year-over-year, reflecting cost control and restructuring efforts.
Company entered and continued corporate restructuring, aiming to exit by summer 2025, with significant operational and contractual changes.
Focus shifted from survival to growth, leveraging existing resources and improved customer contracts in all cities.
Financial highlights
EBITDA for Q1 2025 was -5,038 TSEK, an improvement from -5,584 TSEK in Q1 2024.
Operating loss (EBIT) was -5,921 TSEK, compared to -8,590 TSEK year-over-year.
Cash and bank balances stood at 1,101 TSEK at quarter-end, up from 383 TSEK year-over-year.
Equity at period end was -21,144 TSEK, compared to -20,446 TSEK a year earlier.
Total assets decreased to 12,501 TSEK from 23,176 TSEK year-over-year.
Outlook and guidance
Management expects improved profitability as effects of renegotiated contracts and cost reductions materialize from Q2 2025.
Results for April and possibly May will be published ahead of the half-year report to support the application to exit restructuring.
Latest events from MoveByBike
- Net sales up 63% and net loss reduced, marking a turnaround after restructuring.MBBAB
Q4 202524 Feb 2026 - Restructuring completed, 2025 forecast lowered, but new sales drive targets renewed growth.MBBAB
Status Update8 Dec 2025 - Returned to profitability in Q3 2025 after restructuring, with record delivery growth.MBBAB
Q3 202514 Nov 2025 - Q2 2025 saw 106% revenue growth, reduced losses, and a successful exit from restructuring.MBBAB
Q2 202522 Aug 2025 - Q3 loss deepened after Chainge ApS bankruptcy, but capital actions restore stability.MBBAB
Q3 202413 Jun 2025 - Losses deepened despite new contracts and capital measures; financial risks remain high.MBBAB
Q2 202413 Jun 2025 - Losses deepened despite revenue growth as acquisitions and restructuring weighed on results.MBBAB
Q1 202413 Jun 2025 - Revenue up, but deep losses and negative equity highlight urgent restructuring needs.MBBAB
Q4 20246 Jun 2025